These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12842239)

  • 1. Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris.
    Watanabe K; Ikeda S; Komatsu J; Inaba S; Suzuki J; Sueda S; Funada J; Kitakaze M; Sekiya M
    Am J Cardiol; 2003 Jul; 92(1):21-5. PubMed ID: 12842239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased resting coronary flow and impaired endothelial function in patients with vasospastic angina.
    Saito Y; Kitahara H; Nishi T; Fujimoto Y; Kobayashi Y
    Coron Artery Dis; 2019 Jun; 30(4):291-296. PubMed ID: 30702507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
    Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
    J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.
    Yoo SY; Song SG; Lee JH; Shin ES; Kim JS; Park YH; Kim J; Chun KJ; Kim JH
    Cardiovasc Ther; 2013 Jun; 31(3):179-85. PubMed ID: 22953758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-wire pressure and flow velocity measurement for quantifying microvascular dysfunction in patients with coronary vasospastic angina.
    Yamanaga K; Tsujita K; Komura N; Kaikita K; Sakamoto K; Miyazaki T; Saito M; Ishii M; Tabata N; Akasaka T; Sato K; Horio E; Arima Y; Kojima S; Tayama S; Nakamura S; Hokimoto S; Ogawa H
    Am J Physiol Heart Circ Physiol; 2015 Mar; 308(5):H478-84. PubMed ID: 25527779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina.
    Hori T; Matsubara T; Ishibashi T; Ozaki K; Tsuchida K; Mezaki T; Tanaka T; Nasuno A; Kubota K; Nakamura Y; Yamazoe M; Aizawa Y; Nishio M
    Circ J; 2003 Apr; 67(4):305-11. PubMed ID: 12655160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina.
    Shin ES; Lee JH; Yoo SY; Park Y; Hong YJ; Kim MH; Lee JY; Nam CW; Tahk SJ; Kim JS; Jeong YH; Lee CW; Shin HK; Kim JH
    Heart; 2014 Oct; 100(19):1531-6. PubMed ID: 24934484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation.
    Duffy SJ; Castle SF; Harper RW; Meredith IT
    Circulation; 1999 Nov; 100(19):1951-7. PubMed ID: 10556220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-dependent vasodilator response is augmented in peripheral resistance vessels of patients with vasospastic angina.
    Nakamura M; Yoshida H; Arakawa N; Hiramori K
    Cardiology; 1999; 92(2):85-92. PubMed ID: 10702649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Cilostazol on Endothelial Function as Assessed by Flow-Mediated Dilation in Patients with Coronary Artery Disease.
    Mori H; Maeda A; Wakabayashi K; Sato T; Sasai M; Tashiro K; Iso Y; Ebato M; Suzuki H
    J Atheroscler Thromb; 2016 Oct; 23(10):1168-1177. PubMed ID: 27169919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked Impairment of Endothelium-Dependent Digital Vasodilatations in Patients With Microvascular Angina: Evidence for Systemic Small Artery Disease.
    Ohura-Kajitani S; Shiroto T; Godo S; Ikumi Y; Ito A; Tanaka S; Sato K; Sugisawa J; Tsuchiya S; Suda A; Shindo T; Ikeda S; Hao K; Kikuchi Y; Nochioka K; Matsumoto Y; Takahashi J; Miyata S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1400-1412. PubMed ID: 32237907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of nitric oxide end-products during coronary circulation reflects elevated basal coronary artery tone in patients with vasospastic angina.
    Hori T; Matsubara T; Ishibashi T; Yamazoe M; Ida T; Higuchi K; Takemoto M; Ochiai S; Tamura Y; Aizawa Y; Nishio M
    Jpn Heart J; 2000 Sep; 41(5):583-95. PubMed ID: 11132165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of long-term cilostazol administration on coronary flow velocity and coronary flow reserve].
    Tanaka T; Muneyuki T; Oka Y; Sada T; Kira Y
    J Cardiol; 1999 Oct; 34(4):183-8. PubMed ID: 10553534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.
    Fukuda Y; Teragawa H; Matsuda K; Yamagata T; Matsuura H; Chayama K
    Heart; 2002 Mar; 87(3):264-9. PubMed ID: 11847169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse and severe left ventricular dysfunction induced by epicardial coronary artery spasm.
    Sakata K; Nawada R; Ohbayashi K; Tamekiyo H; Yoshida H
    Angiology; 2000 Oct; 51(10):837-47. PubMed ID: 11108328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cilostazol on impaired vasodilatory response of the brachial artery to ischemia in smokers.
    Oida K; Ebata K; Kanehara H; Suzuki J; Miyamori I
    J Atheroscler Thromb; 2003; 10(2):93-8. PubMed ID: 12740483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms.
    Egashira K; Hirooka Y; Kuga T; Mohri M; Takeshita A
    Circulation; 1996 Jul; 94(2):130-4. PubMed ID: 8674170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary β2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study.
    Puri R; Liew GY; Nicholls SJ; Nelson AJ; Leong DP; Carbone A; Copus B; Wong DT; Beltrame JF; Worthley SG; Worthley MI
    Eur Heart J; 2012 Feb; 33(4):495-504. PubMed ID: 21951627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.